The global dry eye syndrome market reached a value of US$ 3.9 Billion in 2020. Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc. Looking forward, IMARC Group expects the global dry eye syndrome market to exhibit moderate growth during the next five years.
Breakup by Disease Type:
Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.
Breakup by Drug Type:
Based on the drug type, anti-inflammatory drugs currently account for the highest market share.
Breakup by Product:
Based on the product type, liquid eye drops currently account for the highest market share.
Breakup by Distribution Channel:
Based on the distribution type, hospital pharmacies currently account for the highest market share.
Breakup by Region:
On the geographical front, North America currently represents the biggest market for dry eye syndrome.
The competitive landscape of the market has also been examined with some of the key players being, Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
The global dry eye syndrome market reached a value of US$ 3.9 Billion in 2020.
According to the estimates by IMARC Group, the global dry eye syndrome market is expected to exhibit moderate growth during the next five years.
Increasing prevalence of dry eye syndrome as a result of various diseases, such as diabetes, thyroid disorders, lupus, scleroderma, rheumatoid arthritis, etc., represents one of the key drivers for the global dry eye syndrome market.
The growing consumer awareness towards early diagnosis of dry eye syndrome represents one of the key trends in the global dry eye syndrome market.
Sudden outbreak of the COVID-19 pandemic had led to a severe decline in hospital or clinic visits for mitigating the risk of coronavirus infection, thereby negatively impacting the demand for dry eye syndrome diagnosis and treatment procedures.
On the basis of the disease type, the market has been bifurcated into evaporative and aqueous dry eye syndrome. Amongst these, evaporative dry eye syndrome holds the majority of the total market share.
On the basis of the drug type, the market has been classified into lubricant eye drops, anti-inflammatory drugs, and autologous serum eye drops. At present, anti-inflammatory drugs exhibit a clear dominance in the market.
On the basis of the product, the market has been categorized into liquid drops, gel, liquid wipes, eye ointment, and others. Liquid eye drops currently account for the majority of the total market share.
On the basis of the distribution channel, the market has been segregated into retail pharmacies, hospital pharmacies, and online pharmacies. Amongst these, hospital pharmacies currently account for the largest market share.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at